Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.
Carnahan J, Wang P, Kendall R, Chen C, Hu S, Boone T, Juan T, Talvenheimo J, Montestruque S, Sun J, Elliott G, Thomas J, Ferbas J, Kern B, Briddell R, Leonard JP, Cesano A.
Carnahan J, et al. Among authors: sun j.
Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3982S-90S.
Clin Cancer Res. 2003.
PMID: 14506197